Navigation Links
Third in Biological Technology

BioSpecifics Technologies Corp. to Present at CapStone Investments' Third Annual Small-Cap Investor Conference

LYNBROOK, N.Y., July 22 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at the upcoming CapStone Inve...

Varian, Inc. to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results

PALO ALTO, Calif., July 21,/PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) plans to release its financial results for the third quarter of its fiscal year 2009 after 1:00 p.m. Pacific Time (PT) on Wednesday, July 29, 2009. A live webcast (in listen-only mode) of its investor conf...

Nano measurement in the third dimension

This release is available in German . From the motion sensor to the computer chip - in many products of daily life components are used whose functioning is based on smallest structures of the size of thousandths - or even millionths - of millimetres. These micro and nano structures must be...

BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

FRANKLIN LAKES, N.J., June 29 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ) announced today that it will conduct a live webcast of its third fiscal quarter 2009 earnings conference call on Thursday, July 30, 2009 at 10:00 a.m. (EDT). BD will issue a press release d...

WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference

SHANGHAI, June 16 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) today announced that Edward Hu, the Company's Chief Operating Officer and acting Chief Financial Officer, will present at the Third Annual Jefferies Healthcare Conference in New York on Wednesday, June 17, 2009,...

Delcath Systems Granted Third Orphan Drug Designation

NEW YORK, June 2 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ), a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that the United States Food and Drug Administration ("FDA") granted Delcath's a...

China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results

GANSU, China, May 18 /PRNewswire-Asia-FirstCall/ -- China Dasheng Biotechnology Company ("China Dasheng" or "the Company") (OTC Bulletin Board: CDBT), a leading producer and distributor of organic bacteria based additives for crops and livestock feeds in the PRC, announced unaudited financial ...

Corgenix Reports Third Quarter Fiscal 2009 Financial Results

- Revenues for the quarter increase 4.2% vs. prior year - DENVER, May 14 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, today filed its third quarter Form 10-Q and reported financial results. The r...

YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS

MISSISSAUGA, ON, May 14 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI , TSX:YM, AIM:YMBA), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported operational ...

ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program

CLEVELAND, May 6 /PRNewswire/ -- ChanTest, the leading expert in ion channels and GPCRs (G-protein coupled receptors) -- key to drug discovery, development, and safety -- is one of eight organizations slated to receive funding through Ohio's Third Frontier Research and Commercialization Program. G...

Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results

NEW BRUNSWICK, N.J., May 4 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ) today reported financial results for the three months ended March 31, 2009. Net loss for the three month period ended March 31, 2009 was $1,331,477, or $0.07 pe...

Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009

MINNEAPOLIS, April 28 /PRNewswire-FirstCall/ -- Techne Corporation's (Nasdaq: TECH ) consolidated net earnings for the quarter ended March 31, 2009 decreased 6.6% to $27.6 million or $.74 per diluted share compared with $29.6 million or $.76 per diluted share for the quarter ended March 31, 2008...

PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results

- Consolidated service revenue of $264.5 million grows 7.8% year-over-year - Operating margin of 10.0% - Diluted earnings per share of $0.25 - Net quarterly book-to-bill ratio equates to 1.25 BOSTON, April 27 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: ...

Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results

LAVAL, QC, April 14 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) provides guidance for the expected financial results of the fiscal 2009 third quarter and nine-month period ended February 28, 2009. These results represent the year-end...

Neogen Reports Record Third Quarter

LANSING, Mich., March 19 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG ) announced today that despite obstacles posed by the declining global economy, its third quarter revenues increased 11% to $27,840,000, a record third quarter for the 26-year-old company, compared to the prior y...

Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results

BALTIMORE, March 18 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, reports its financial results for the third fiscal quarter ...

US Oncology Named to FORTUNE Magazine's Most Admired Companies List for Third Time

HOUSTON, March 12 /PRNewswire/ -- US Oncology, Inc ., one of the nation's largest cancer care services companies, has been named to FORTUNE magazine's Most Admired Companies list for 2009. The company ranks third in the Health Care: Pharmacy and Other category. This is the third time US On...

Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon

SUNNYVALE, Calif., Feb. 17 /PRNewswire/ -- Avantis Medical Systems, Inc., a technology leader in developing novel chip-on-catheter digital imaging devices, announced today that it has received a new 510(k) clearance for its Third Eye(R) Retroscope(R) (Third Eye), supporting the claim for increased...

On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability

ANN ARBOR, Mich., Feb. 10 /PRNewswire/ -- Compendia Bioscience, Inc. today announced the results of a third productive year, including a 100 percent renewal rate from its customers. New customers and increased commitments from existing customers, including multi-year agreements from three of the T...

Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008

TOKYO, February 5 /PRNewswire-FirstCall/ -- HOYA Corporation today announced financial results for the third quarter ended December 31, 2008. Net sales were 112.7 billion yen for the quarter, representing a decrease of 23.3% from 147.0 billion yen in the third quarter of 2007, mainly due to or...

Repligen Reports Third Quarter Fiscal Year 2009 Financial Results

WALTHAM, Mass., Feb. 5 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) today reported results for the third quarter of fiscal year 2009, ended December 31, 2008. Total revenue for the quarter was $6,018,000 compared to $4,664,000 for the third quarter of fiscal year 2008. Total ...

Uroplasty Reports Third Quarter Fiscal 2009 Results

MINNEAPOLIS, Feb. 3 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the third quarter of fiscal 2009 ended December 31,...

Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results

Thursday, February 5th, 10:00 a.m. EST WALTHAM, Mass., Jan. 29 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, February 5th,...

Abaxis to Report Third Quarter Fiscal 2009 Financial Results Thursday, January 29, 2009

UNION CITY, Calif., Jan. 22 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the third quarter of fiscal year 2009, ended December 31, 2008. ...

Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso

REHOVOT, Israel, JERSEY CITY, New Jersey and PHILADELPHIA, Pennsylvania, December 29 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), the leading developer of microRNA-based molecular diagnostics, announced today the introduction of its third diagnostic test, miRview(TM) meso. T...

Probiotic Delivery Technology Awarded Third International Patent

REDMOND, Wash., Dec. 16 /PRNewswire/ -- The Australian Patent Office has issued Nutraceutix, Inc. a patent for BIO-tract. It is the third international patent, from many patents pending, that the technology has been awarded based on BIO-tract's ability to protect sensitive ingredients like probiot...

Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS

REHOVOT, Israel and JERSEY CITY, New Jersey, December 5 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG ), an innovative molecular diagnostic company leveraging microRNAs as biomarkers, reported today its consolidated financial results for the quarter ended September 30, 2008 ...

Ernst & Young Benchmarks Danish Biotech Pipeline Third in Europe

COPENHAGEN, December 1 /PRNewswire/ -- A strong pipeline makes the Copenhagen Region biotech cluster well prepared for the challenges ahead. With 185 drug candidates in preclinical and clinical development, Denmark ranks third in Europe. Only United Kingdom and Germany have a bigger pipeline. ...

Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing

WAYNE, Pa., Nov. 28 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO ), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that on Novemb...

Encorium Reports Third Quarter 2008 Financial Results

-- New business wins increase 400% to $16 million in third quarter 2008; up 40% year-to-date -- Results include $1.9 million non-cash goodwill impairment charge WAYNE, Pa., Nov. 26 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO ) , a full service multinational c...

Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results

REHOVOT, Israel and JERSEY CITY, New Jersey, November 26 /PRNewswire-FirstCall/ -- Rosetta Genomics (Nasdaq: ROSG ), today announced it will release third quarter financial results on December 5, 2008, before the U.S. markets open. Rosetta Genomics will host a conference call with a simultan...

Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results

LA JOLLA, Calif., Nov. 20 /PRNewswire-FirstCall/ -- Duska Therapeutics, Inc. (OTC Bulletin Board: DSKA) will host a teleconference call today at 2:30 p.m. EST to review its drug development programs and financial results for the third quarter of 2008. Duska's chief executive officer, James S. Kuo,...

Sinovac Reports Third Quarter 2008 Unaudited Financial Results

BEIJING, Nov. 18 /PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA ), a leading developer and provider of vaccines in China, today announced the Company's financial results for the three-month and nine-month periods ended September 30, 2008. Highlights -- Sales year-to-date increased ...

Benda Pharmaceutical Reports Third Quarter 2008 Financial Results

HUBEI PROVINCE, China, Nov. 18 /PRNewswire-FirstCall/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, ...

Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results

Conference Call To Be Held Friday, November 14, 2008 at 9:00 a.m. Eastern Time HOPKINTON, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE ) today reports operational and financial results for the quarter ended September 30, ...

Pharmathene Reports Third Quarter 2008 Financial and Operational Results

ANNAPOLIS, Md., Nov. 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Alternext US: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the third quarter and nine months ended September ...

Interleukin Genetics Reports Third Quarter 2008 Financial Results

WALTHAM, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI ) today announced financial and business results for the third quarter ended September 30, 2008. The Company reported a net loss of $1.6 million, or $(.05) per basic and diluted common share, for the thi...

Cardiogenesis Reports Third Quarter 2008 Results

IRVINE, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products used in the treatment of patients suffering from severe angina, today reported financial results for its third quarter ended September 30, 2008. Third Qua...

AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results

All amounts are in U.S. dollars QUEBEC CITY, Nov. 13 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS , TSX: AEZ), a global biopharmaceutical company focused on endocrinology and oncology, today reported financial and operating results for the third quarter ended September 30, 2...

Yongye Biotechnology Announces Record Third Quarter Results

BEIJING, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the "Company"), a leading developer, producer and distributor of nutrients for plants and animals in the People's Republic of China, today announced its financial r...
Other Tags
(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
Other Contents